As the global economy mends, the 2021 growth of Influenza Virus Vaccine (H1N1) will have significant change from previous year. According to our (LP Information) latest study, the global Influenza Virus Vaccine (H1N1) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Influenza Virus Vaccine (H1N1) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Influenza Virus Vaccine (H1N1) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Influenza Virus Vaccine (H1N1) market, reaching US$ million by the year 2028. As for the Europe Influenza Virus Vaccine (H1N1) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Influenza Virus Vaccine (H1N1) players cover CSL, NVS(Novartis), Sanofi Pasteur, and Medimmune, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Virus Vaccine (H1N1) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Intramuscular Vaccine
- Nasal Spray Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
- 3 To 10 Years Old
- 10 To 18 Years Old
- Above 18 Years Old
- Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
- CSL
- NVS(Novartis)
- Sanofi Pasteur
- Medimmune
- GSK
- Baxter
- Beijing Kexing Bio-Vaccine
- Hualan Bio-Vaccine
- Changchun Changsheng Bio-Technology
- Beijing Tiantan Bio-Products
- Jiangsu Yanshen Bio-Technology
- Zhejiang Tianyuan Bio-Pharmaceutical
- Dalian Yalifeng Bio-Pharmaceutical
- Sinopharm
Global Influenza Virus Vaccine (H1N1) Market Growth 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Country/Region, 2017, 2022 & 2028
2.2 Influenza Virus Vaccine (H1N1) Segment by Type
2.2.1 Intramuscular Vaccine
2.2.2 Nasal Spray Vaccine
2.3 Influenza Virus Vaccine (H1N1) Sales by Type
2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
2.3.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2017-2022)
2.4 Influenza Virus Vaccine (H1N1) Segment by Application
2.4.1 3 To 10 Years Old
2.4.2 10 To 18 Years Old
2.4.3 Above 18 Years Old
2.4.4 Other
2.5 Influenza Virus Vaccine (H1N1) Sales by Application
2.5.1 Global Influenza Virus Vaccine (H1N1) Sale Market Share by Application (2017-2022)
2.5.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2017-2022)
3 Global Influenza Virus Vaccine (H1N1) by Company
3.1 Global Influenza Virus Vaccine (H1N1) Breakdown Data by Company
3.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Company (2020-2022)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2020-2022)
3.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Company (2020-2022)
3.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Company (2020-2022)
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2020-2022)
3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Company
3.4 Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Virus Vaccine (H1N1) Product Location Distribution
3.4.2 Players Influenza Virus Vaccine (H1N1) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Influenza Virus Vaccine (H1N1) by Geographic Region
4.1 World Historic Influenza Virus Vaccine (H1N1) Market Size by Geographic Region (2017-2022)
4.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Geographic Region
4.2 World Historic Influenza Virus Vaccine (H1N1) Market Size by Country/Region (2017-2022)
4.2.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Country/Region
4.3 Americas Influenza Virus Vaccine (H1N1) Sales Growth
4.4 APAC Influenza Virus Vaccine (H1N1) Sales Growth
4.5 Europe Influenza Virus Vaccine (H1N1) Sales Growth
4.6 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Growth
5 Americas
5.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country
5.1.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022)
5.1.2 Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022)
5.2 Americas Influenza Virus Vaccine (H1N1) Sales by Type
5.3 Americas Influenza Virus Vaccine (H1N1) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region
6.1.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022)
6.1.2 APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022)
6.2 APAC Influenza Virus Vaccine (H1N1) Sales by Type
6.3 APAC Influenza Virus Vaccine (H1N1) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Influenza Virus Vaccine (H1N1) by Country
7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022)
7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022)
7.2 Europe Influenza Virus Vaccine (H1N1) Sales by Type
7.3 Europe Influenza Virus Vaccine (H1N1) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Influenza Virus Vaccine (H1N1) by Country
8.1.1 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022)
8.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type
8.3 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Virus Vaccine (H1N1)
10.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
10.4 Industry Chain Structure of Influenza Virus Vaccine (H1N1)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Virus Vaccine (H1N1) Distributors
11.3 Influenza Virus Vaccine (H1N1) Customer
12 World Forecast Review for Influenza Virus Vaccine (H1N1) by Geographic Region
12.1 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Region
12.1.1 Global Influenza Virus Vaccine (H1N1) Forecast by Region (2023-2028)
12.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza Virus Vaccine (H1N1) Forecast by Type
12.7 Global Influenza Virus Vaccine (H1N1) Forecast by Application
13 Key Players Analysis
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Influenza Virus Vaccine (H1N1) Product Offered
13.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 NVS(Novartis)
13.2.1 NVS(Novartis) Company Information
13.2.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Offered
13.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 NVS(Novartis) Main Business Overview
13.2.5 NVS(Novartis) Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Offered
13.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Medimmune
13.4.1 Medimmune Company Information
13.4.2 Medimmune Influenza Virus Vaccine (H1N1) Product Offered
13.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Medimmune Main Business Overview
13.4.5 Medimmune Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Influenza Virus Vaccine (H1N1) Product Offered
13.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Baxter
13.6.1 Baxter Company Information
13.6.2 Baxter Influenza Virus Vaccine (H1N1) Product Offered
13.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Baxter Main Business Overview
13.6.5 Baxter Latest Developments
13.7 Beijing Kexing Bio-Vaccine
13.7.1 Beijing Kexing Bio-Vaccine Company Information
13.7.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered
13.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Beijing Kexing Bio-Vaccine Main Business Overview
13.7.5 Beijing Kexing Bio-Vaccine Latest Developments
13.8 Hualan Bio-Vaccine
13.8.1 Hualan Bio-Vaccine Company Information
13.8.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered
13.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hualan Bio-Vaccine Main Business Overview
13.8.5 Hualan Bio-Vaccine Latest Developments
13.9 Changchun Changsheng Bio-Technology
13.9.1 Changchun Changsheng Bio-Technology Company Information
13.9.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered
13.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Changchun Changsheng Bio-Technology Main Business Overview
13.9.5 Changchun Changsheng Bio-Technology Latest Developments
13.10 Beijing Tiantan Bio-Products
13.10.1 Beijing Tiantan Bio-Products Company Information
13.10.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Offered
13.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Beijing Tiantan Bio-Products Main Business Overview
13.10.5 Beijing Tiantan Bio-Products Latest Developments
13.11 Jiangsu Yanshen Bio-Technology
13.11.1 Jiangsu Yanshen Bio-Technology Company Information
13.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered
13.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jiangsu Yanshen Bio-Technology Main Business Overview
13.11.5 Jiangsu Yanshen Bio-Technology Latest Developments
13.12 Zhejiang Tianyuan Bio-Pharmaceutical
13.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
13.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered
13.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview
13.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
13.13 Dalian Yalifeng Bio-Pharmaceutical
13.13.1 Dalian Yalifeng Bio-Pharmaceutical Company Information
13.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered
13.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Dalian Yalifeng Bio-Pharmaceutical Main Business Overview
13.13.5 Dalian Yalifeng Bio-Pharmaceutical Latest Developments
13.14 Sinopharm
13.14.1 Sinopharm Company Information
13.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Offered
13.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sinopharm Main Business Overview
13.14.5 Sinopharm Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intramuscular Vaccine
Table 4. Major Players of Nasal Spray Vaccine
Table 5. Global Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
Table 7. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2022)
Table 9. Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
Table 12. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022)
Table 13. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2022)
Table 14. Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global Influenza Virus Vaccine (H1N1) Sales by Company (2020-2022) & (K Doses)
Table 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2020-2022)
Table 17. Global Influenza Virus Vaccine (H1N1) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2020-2022)
Table 19. Global Influenza Virus Vaccine (H1N1) Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution and Sales Area
Table 21. Players Influenza Virus Vaccine (H1N1) Products Offered
Table 22. Influenza Virus Vaccine (H1N1) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Influenza Virus Vaccine (H1N1) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Influenza Virus Vaccine (H1N1) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Influenza Virus Vaccine (H1N1) Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Influenza Virus Vaccine (H1N1) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)
Table 35. Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)
Table 37. Americas Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
Table 39. Americas Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
Table 41. APAC Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
Table 43. APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2017-2022)
Table 45. APAC Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
Table 47. APAC Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
Table 49. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)
Table 51. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)
Table 53. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
Table 55. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Influenza Virus Vaccine (H1N1)
Table 66. Key Market Challenges & Risks of Influenza Virus Vaccine (H1N1)
Table 67. Key Industry Trends of Influenza Virus Vaccine (H1N1)
Table 68. Influenza Virus Vaccine (H1N1) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Influenza Virus Vaccine (H1N1) Distributors List
Table 71. Influenza Virus Vaccine (H1N1) Customer List
Table 72. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Influenza Virus Vaccine (H1N1) Sales Market Forecast by Region
Table 74. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Influenza Virus Vaccine (H1N1) Product Offered
Table 94. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. CSL Main Business
Table 96. CSL Latest Developments
Table 97. NVS(Novartis) Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 98. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Offered
Table 99. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. NVS(Novartis) Main Business
Table 101. NVS(Novartis) Latest Developments
Table 102. Sanofi Pasteur Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Offered
Table 104. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. Sanofi Pasteur Main Business
Table 106. Sanofi Pasteur Latest Developments
Table 107. Medimmune Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 108. Medimmune Influenza Virus Vaccine (H1N1) Product Offered
Table 109. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 110. Medimmune Main Business
Table 111. Medimmune Latest Developments
Table 112. GSK Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK Influenza Virus Vaccine (H1N1) Product Offered
Table 114. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
Table 117. Baxter Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 118. Baxter Influenza Virus Vaccine (H1N1) Product Offered
Table 119. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 120. Baxter Main Business
Table 121. Baxter Latest Developments
Table 122. Beijing Kexing Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered
Table 124. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 125. Beijing Kexing Bio-Vaccine Main Business
Table 126. Beijing Kexing Bio-Vaccine Latest Developments
Table 127. Hualan Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 128. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered
Table 129. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 130. Hualan Bio-Vaccine Main Business
Table 131. Hualan Bio-Vaccine Latest Developments
Table 132. Changchun Changsheng Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 133. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered
Table 134. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 135. Changchun Changsheng Bio-Technology Main Business
Table 136. Changchun Changsheng Bio-Technology Latest Developments
Table 137. Beijing Tiantan Bio-Products Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 138. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Offered
Table 139. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 140. Beijing Tiantan Bio-Products Main Business
Table 141. Beijing Tiantan Bio-Products Latest Developments
Table 142. Jiangsu Yanshen Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered
Table 144. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 145. Jiangsu Yanshen Bio-Technology Main Business
Table 146. Jiangsu Yanshen Bio-Technology Latest Developments
Table 147. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 148. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered
Table 149. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 150. Zhejiang Tianyuan Bio-Pharmaceutical Main Business
Table 151. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
Table 152. Dalian Yalifeng Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 153. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered
Table 154. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 155. Dalian Yalifeng Bio-Pharmaceutical Main Business
Table 156. Dalian Yalifeng Bio-Pharmaceutical Latest Developments
Table 157. Sinopharm Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 158. Sinopharm Influenza Virus Vaccine (H1N1) Product Offered
Table 159. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 160. Sinopharm Main Business
Table 161. Sinopharm Latest Developments
List of Figures
Figure 1. Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Influenza Virus Vaccine (H1N1) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Influenza Virus Vaccine (H1N1) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intramuscular Vaccine
Figure 10. Product Picture of Nasal Spray Vaccine
Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2021
Figure 12. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2022)
Figure 13. Influenza Virus Vaccine (H1N1) Consumed in 3 To 10 Years Old
Figure 14. Global Influenza Virus Vaccine (H1N1) Market: 3 To 10 Years Old (2017-2022) & (K Doses)
Figure 15. Influenza Virus Vaccine (H1N1) Consumed in 10 To 18 Years Old
Figure 16. Global Influenza Virus Vaccine (H1N1) Market: 10 To 18 Years Old (2017-2022) & (K Doses)
Figure 17. Influenza Virus Vaccine (H1N1) Consumed in Above 18 Years Old
Figure 18. Global Influenza Virus Vaccine (H1N1) Market: Above 18 Years Old (2017-2022) & (K Doses)
Figure 19. Influenza Virus Vaccine (H1N1) Consumed in Other
Figure 20. Global Influenza Virus Vaccine (H1N1) Market: Other (2017-2022) & (K Doses)
Figure 21. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
Figure 22. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application in 2021
Figure 23. Influenza Virus Vaccine (H1N1) Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company in 2021
Figure 25. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region in 2021
Figure 27. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
Figure 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Country/Region in 2021
Figure 29. Americas Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)
Figure 30. Americas Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)
Figure 31. APAC Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)
Figure 32. APAC Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)
Figure 33. Europe Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)
Figure 34. Europe Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)
Figure 36. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)
Figure 37. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2021
Figure 38. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2021
Figure 39. United States Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2021
Figure 44. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Regions in 2021
Figure 45. China Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2021
Figure 52. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2021
Figure 53. Germany Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millio
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
